Skip links and keyboard navigation

Department of Environment and Science

Queensland Government

Science portfolio of the Department of Environment and Science

Department of Environment and Science

Queensland science capability directory

Back to directory

Translational Research Institute (TRI)

Hands of a researcher sorting test tubes

Australia's Translational Research Institute (TRI) combines the intellect and resources of The University of Queensland, Mater Research, Queensland University of Technology, and Queensland Health in an innovative research, development and translation facility. Located with the Princess Alexandra Hospital and biopharmaceutical manufacturer, Patheon Biologics, TRI is developing a new generation of scientists and clinicians who can work with industry to transform Australia's international competitiveness and improve health outcomes worldwide. To this end TRI is at the interface of science, medicine and industry in preventing, diagnosing and treating human diseases.

Website www.tri.edu.au

Key science sectors

Strengths and capabilities

  • Immunotherapy
  • Diagnostic imaging
  • Metabolomics
  • Translational biomedical research
  • Cancer research
  • Emerging technologies for diagnosing disease and trauma
  • Technologies for Dermatology
  • Vaccine development
  • Gastroenterology and Hepatology
  • Genomics

Facilities and major equipment

  • Innovation and Translation Centre
  • Clinical Research Facility
  • Biological Research Facility
  • Flow Cytometry
  • Proteomics
  • Preclinical imaging
  • Microscopy
  • Centre for Clinical Genomics
  • PET MRI

Number of research staff

700 plus research staff

Address

37 Kent Street , Woolloongabba, Queensland, 4102

Lead researchers

Achievements of the centre

  • New magnetic resonance spectroscopy (MRS) that detects chemical changes in breast and brain for cancers and brain injuries.
  • New treatments for autoimmune diseases, such as rheumatoid arthritis, that target the underlying cause of the disease.
  • Results from clinical trials of a vaccine for the herpes simplex virus (HSV) has performed well in Phase 1 clinical trials.

Organisation type

  • Business - private company - Queensland-based
  • Queensland Government – Partner
  • University Research Centre

Help us improve this directory by taking a short survey. Take the survey (new window)

Register your centre

Register your centre to be listed in this directory.

Last updated:
6 September 2018